These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

364 related articles for article (PubMed ID: 37928478)

  • 21. Bacteriophage biocontrol in animals and meat products.
    Atterbury RJ
    Microb Biotechnol; 2009 Nov; 2(6):601-12. PubMed ID: 21255295
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Bacteriophages: The promising therapeutic approach for enhancing ciprofloxacin efficacy against bacterial infection.
    Shariati A; Noei M; Chegini Z
    J Clin Lab Anal; 2023 May; 37(9-10):e24932. PubMed ID: 37377167
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Bacteriophage Therapy: Clinical Trials and Regulatory Hurdles.
    Furfaro LL; Payne MS; Chang BJ
    Front Cell Infect Microbiol; 2018; 8():376. PubMed ID: 30406049
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Phage therapy of wound-associated infections.
    Zyman A; Górski A; Międzybrodzki R
    Folia Microbiol (Praha); 2022 Apr; 67(2):193-201. PubMed ID: 35028881
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Isolation, characterization, therapeutic potency, and genomic analysis of a novel bacteriophage vB_KshKPC-M against carbapenemase-producing Klebsiella pneumoniae strains (CRKP) isolated from Ventilator-associated pneumoniae (VAP) infection of COVID-19 patients.
    Mohammadi M; Saffari M; Siadat SD; Hejazi SH; Shayestehpour M; Motallebi M; Eidi M
    Ann Clin Microbiol Antimicrob; 2023 Feb; 22(1):18. PubMed ID: 36829156
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Ameliorating the antimicrobial resistance crisis: phage therapy.
    Saha D; Mukherjee R
    IUBMB Life; 2019 Jul; 71(7):781-790. PubMed ID: 30674079
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Basic Guidelines for Bacteriophage Isolation and Characterization.
    Samir S
    Recent Pat Biotechnol; 2023; 17(4):312-331. PubMed ID: 36263478
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Biological aspects of phage therapy versus antibiotics against
    Kosznik-Kwaśnicka K; Podlacha M; Grabowski Ł; Stasiłojć M; Nowak-Zaleska A; Ciemińska K; Cyske Z; Dydecka A; Gaffke L; Mantej J; Myślińska D; Necel A; Pierzynowska K; Piotrowska E; Radzanowska-Alenowicz E; Rintz E; Sitko K; Topka-Bielecka G; Węgrzyn G; Węgrzyn A
    Front Cell Infect Microbiol; 2022; 12():941867. PubMed ID: 35992162
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Potential of Therapeutic Bacteriophages in Nosocomial Infection Management.
    Wu N; Zhu T
    Front Microbiol; 2021; 12():638094. PubMed ID: 33633717
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Bacteriophages and antibiotic interactions in clinical practice: what we have learned so far.
    Łusiak-Szelachowska M; Międzybrodzki R; Drulis-Kawa Z; Cater K; Knežević P; Winogradow C; Amaro K; Jończyk-Matysiak E; Weber-Dąbrowska B; Rękas J; Górski A
    J Biomed Sci; 2022 Mar; 29(1):23. PubMed ID: 35354477
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pharmacologically Aware Phage Therapy: Pharmacodynamic and Pharmacokinetic Obstacles to Phage Antibacterial Action in Animal and Human Bodies.
    Dąbrowska K; Abedon ST
    Microbiol Mol Biol Rev; 2019 Nov; 83(4):. PubMed ID: 31666296
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The resurgence of phage-based therapy in the era of increasing antibiotic resistance: From research progress to challenges and prospects.
    Anyaegbunam NJ; Anekpo CC; Anyaegbunam ZKG; Doowuese Y; Chinaka CB; Odo OJ; Sharndama HC; Okeke OP; Mba IE
    Microbiol Res; 2022 Nov; 264():127155. PubMed ID: 35969943
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Clinical Indications and Compassionate Use of Phage Therapy: Personal Experience and Literature Review with a Focus on Osteoarticular Infections.
    Patey O; McCallin S; Mazure H; Liddle M; Smithyman A; Dublanchet A
    Viruses; 2018 Dec; 11(1):. PubMed ID: 30597868
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The use of bacteriophages against saprophytic mesophilic bacteria in minimally processed food.
    Wójcicki M; Żuwalski A; Świder O; Gientka I; Shymialevich D; Błażejak S
    Acta Sci Pol Technol Aliment; 2021; 20(4):473-484. PubMed ID: 34724371
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Bacteriophage Treatment before Chemical Disinfection Can Enhance Removal of Plastic-Surface-Associated Pseudomonas aeruginosa.
    Stachler E; Kull A; Julian TR
    Appl Environ Microbiol; 2021 Sep; 87(20):e0098021. PubMed ID: 34347517
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Current review-The rise of bacteriophage as a unique therapeutic platform in treating peri-prosthetic joint infections.
    Akanda ZZ; Taha M; Abdelbary H
    J Orthop Res; 2018 Apr; 36(4):1051-1060. PubMed ID: 28971508
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Efficacy of Phage- and Bacteriocin-Based Therapies in Combatting Nosocomial MRSA Infections.
    Walsh L; Johnson CN; Hill C; Ross RP
    Front Mol Biosci; 2021; 8():654038. PubMed ID: 33996906
    [No Abstract]   [Full Text] [Related]  

  • 38. The Rapid Development and Early Success of Covid 19 Vaccines Have Raised Hopes for Accelerating the Cancer Treatment Mechanism.
    Amanpour S
    Arch Razi Inst; 2021 Mar; 76(1):1-6. PubMed ID: 33818952
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Growing Trend of Fighting Infections in Aquaculture Environment-Opportunities and Challenges of Phage Therapy.
    Kowalska JD; Kazimierczak J; Sowińska PM; Wójcik EA; Siwicki AK; Dastych J
    Antibiotics (Basel); 2020 Jun; 9(6):. PubMed ID: 32512805
    [TBL] [Abstract][Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.